HIHironobu Ishimaru
Hironobu Ishimaru
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hironobu Ishimaru has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Takenobu Yamamoto
Department of Dermatology Kawasaki Medical School Okayama Japan
3 shared publications - Yumi Aoyama
Department of Dermatology Kawasaki Medical School Kurashiki Japan
3 shared publications - Kenta Nakamoto
Department of Dermatology, Kawasaki Medical School, Kurashiki, Japan
2 shared publications - Mariko Yamane
Department of Dermatology Kawasaki Medical School General Medical Center Okayama Japan
2 shared publications - Kazuhito Tsuboi
Department of Pharmacology, Kawasaki Medical School, Kurashiki, Japan
1 shared publication - Keisuke Kitakaze
Department of Pharmacology, Kawasaki Medical School, Kurashiki, Japan
1 shared publication
Latest Publications
- Open Access
- 4 November 2026
- Published by Elsevier in JID Innovations
Desmoglein-3 Deficiency Restricts Cutaneous HSV-1 Infection by Acantholysis-Mediated Disruption of Cell-to-Cell Transmission
- 4 November 2026
- Published by Elsevier in JID Innovations
Open AccessDesmoglein-3 Deficiency Restricts Cutaneous HSV-1 Infection by Acantholysis-Mediated Disruption of Cell-to-Cell Transmission
- Open Access
- 22 March 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (10) , 2211-2220.e6
Sweat Protects against Contact Hypersensitivity: Transient Sweat Suppression Compromises Skin Barrier Function in Mice
- 22 March 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (10) , 2211-2220.e6
Open AccessSweat Protects against Contact Hypersensitivity: Transient Sweat Suppression Compromises Skin Barrier Function in Mice
- Open Access
- 22 September 2014
- Published by Wiley in Journal of Veterinary Medicine
- Vol. 2014, 1-5
Influence of a Diester Glucocorticoid Spray on the Cortisol Level and the CCR4+CD4+Lymphocytes in Dogs with Atopic Dermatitis: Open Study
This study investigated the influence of 0.00584% hydrocortisone aceponate spray (HCA; Cortavance Virbac SA, Carros, France) on blood serum cortisol levels and peripheral blood CCR4+CD4+T-lymphocyte levels in dogs with atopic dermatitis. Patients were randomly divided into group I () and group II (). The dogs in group I were sprayed with HCA on the affected skin once a day for three weeks. The dogs in group II were treated once a day for 3 days followed by no treatment for 4 days for a total of three weeks. For the dogs in group I and group II the CADESI-03 scores before and after use of HCA showed significant reduction (). The postcortisol level after the use of HCA in group I showed 36.0% decrease and showed significant suppression (). By comparison, the use of HCA on group II did not show decrease in postcortisol levels. There was a tendency of suppression for hypothalamus—pituitary gland—adrenal gland system, but it was not serious influence. In addition, there was no influence on peripheral blood CCR4+CD4+lymphocytes percentage in dogs in group I after treatment with HCA.Corrigendum to “Influence of a Diester Glucocorticoid Spray on the Cortisol Level and the CCR4+CD4+Lymphocytes in Dogs with Atopic Dermatitis: Open Study”- 22 September 2014
- Published by Wiley in Journal of Veterinary Medicine
- Vol. 2014, 1-5
Open AccessInfluence of a Diester Glucocorticoid Spray on the Cortisol Level and the CCR4+CD4+Lymphocytes in Dogs with Atopic Dermatitis: Open Study
This study investigated the influence of 0.00584% hydrocortisone aceponate spray (HCA; Cortavance Virbac SA, Carros, France) on blood serum cortisol levels and peripheral blood CCR4+CD4+T-lymphocyte levels in dogs with atopic dermatitis. Patients were randomly divided into group I () and group II (). The dogs in group I were sprayed with HCA on the affected skin once a day for three weeks. The dogs in group II were treated once a day for 3 days followed by no treatment for 4 days for a total of three weeks. For the dogs in group I and group II the CADESI-03 scores before and after use of HCA showed significant reduction (). The postcortisol level after the use of HCA in group I showed 36.0% decrease and showed significant suppression (). By comparison, the use of HCA on group II did not show decrease in postcortisol levels. There was a tendency of suppression for hypothalamus—pituitary gland—adrenal gland system, but it was not serious influence. In addition, there was no influence on peripheral blood CCR4+CD4+lymphocytes percentage in dogs in group I after treatment with HCA.Corrigendum to “Influence of a Diester Glucocorticoid Spray on the Cortisol Level and the CCR4+CD4+Lymphocytes in Dogs with Atopic Dermatitis: Open Study”